COT Statement on hexabromocyclododecanes (HBCDDs)

Last updated:
7 April 2015
The Scientific Advisory Committee on Nutrition is reviewing scientific evidence that bears on dietary recommendations for infants and young children. The COT is considering risks that might need to be taken into account. This statement summarises the evidence on risks from hexabromocyclododecanes (HBCDDs) in the infant diet and the conclusions of the COT